Cerus Corporation (CERS) Estados Financieros e Histórico

Cerus Corporation (CERS) — Precio $2.53 HealthcareMedical - Devices — NASDAQ

Últimos resultados publicados:

Estados financieros detallados de Cerus Corporation (CERS): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.

Resumen del Análisis

Cerus Corporation registró ingresos de $206.1M en el último ejercicio fiscal, con un CAGR de 5 años del 17.5%.

Márgenes de los últimos 12 meses: margen bruto 52.0%, margen operativo -0.7%, margen neto -3.1%.

Al precio actual de $2.53, CERS presenta beneficios negativos (P/E no significativo) y un ROE del -10.31%. La capitalización bursátil es de $510M.

Cuenta de Resultados (10 años)

Año2016201720182019202020212022202320242025
Ingresos$37.2M$43.6M$60.9M$74.6M$91.9M$130.9M$162.0M$156.4M$180.3M$206.1M
Coste de Ventas$20.3M$22.5M$31.6M$33.4M$41.2M$63.5M$75.0M$70.0M$80.7M$93.8M
Beneficio Bruto$16.9M$21.0M$29.3M$41.2M$50.8M$67.4M$87.1M$86.4M$99.5M$112.3M
I+D$31.3M$33.7M$42.6M$60.4M$64.4M$63.7M$64.1M$67.6M$58.9M$67.7M
Generales y Administrativos$48.8M$52.4M$56.8M$66.2M$67.0M$81.3M$83.3M$75.5M$75.9M$80.9M
Gastos Operativos$78.2M$78.6M$84.3M$107.5M$109.1M$116.3M$121.2M$116.5M$113.7M$121.0M
Beneficio Operativo-$61.4M-$57.5M-$55.0M-$66.2M-$58.3M-$48.9M-$34.1M-$30.1M-$14.2M-$8.7M
EBITDA-$58.5M-$51.9M-$51.9M-$64.6M-$51.4M-$46.0M-$33.5M-$26.3M-$10.0M-$5.5M
Gastos por Intereses$2.4M$3.0M$4.0M$6.1M$3.7M$4.9M$5.8M$8.4M$8.9M$8.3M
Beneficio Antes de Impuestos-$62.7M-$56.7M-$57.3M-$71.0M-$59.6M-$54.1M-$42.3M-$37.3M-$20.8M-$15.3M
Impuestos$175000$3.9M$229000$263000$284000$319000$488000$325000$205000$354000
Beneficio Neto-$62.9M-$60.6M-$57.6M-$71.2M-$59.9M-$54.4M-$42.8M-$37.5M-$20.9M-$15.6M
BPA$-0.62$-0.56$-0.44$-0.51$-0.37$-0.32$-0.24$-0.21$-0.11$-0.08
BPA Diluido$-0.62$-0.56$-0.44$-0.51$-0.37$-0.32$-0.24$-0.21$-0.11$-0.08
Acciones en Circulación (Diluidas)$101.8M$108.2M$131.7M$139.8M$163.9M$171.3M$176.5M$180.3M$184.6M$190.6M

Cuenta de Resultados (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Ingresos$52.7M$57.8M$53.7M$57.4M
Beneficio Bruto$28.1M$29.7M$27.9M$29.5M
Beneficio Operativo$1.2M-$641000-$354000-$1.9M
EBITDA$2.6M$292000$762000-$712000
Beneficio Neto-$19000-$2.2M-$1.6M-$2.9M
BPA$-0.00$-0.01$-0.01$-0.01
BPA Diluido$-0.00$-0.01$-0.01$-0.01

Balance (10 años)

Año2016201720182019202020212022202320242025
Caja y Equivalentes$22.6M$13.7M$28.9M$35.0M$36.6M$48.8M$35.6M$11.6M$20.3M$20.0M
Inversiones a Corto$49.1M$47.0M$88.7M$50.7M$97.0M$80.6M$66.6M$54.2M$60.2M$62.9M
Cuentas por Cobrar$6.9M$12.4M$8.8M$16.9M$21.2M$25.1M$34.4M$35.5M$29.8M$30.4M
Inventario$12.5M$14.5M$13.5M$19.5M$23.3M$26.8M$29.0M$39.9M$38.1M$56.1M
Activos Corrientes$94.1M$89.9M$146.9M$128.1M$183.4M$187.1M$170.1M$144.4M$152.0M$174.4M
Inmovilizado Material$3.0M$2.1M$8.1M$29.0M$27.0M$25.2M$23.5M$19.4M$15.5M$19.3M
Fondo de Comercio$1.3M$1.3M$1.3M$1.3M$1.3M$1.3M$1.3M$1.3M$1.3M$1.3M
Activos Intangibles$738000$536000$334000$132000000000
Activos Totales$103.5M$98.2M$163.5M$165.5M$221.4M$237.5M$218.1M$197.7M$200.9M$221.9M
Cuentas por Pagar$8.6M$11.0M$18.6M$22.2M$24.2M$35.6M$33.0M$23.8M$21.7M$28.0M
Deuda a Corto$6.9M0$7.9M$5.0M$8.5M$14.7M$56.2M$20.0M$19.3M$43.3M
Pasivos Corrientes$26.9M$23.1M$52.7M$50.3M$60.0M$78.6M$117.1M$67.5M$63.6M$100.8M
Deuda a Largo$12.4M$29.8M$22.0M$39.4M$39.6M$54.7M$13.6M$59.8M$64.9M$40.5M
Pasivos Totales$45.7M$59.3M$78.9M$108.5M$117.6M$151.9M$149.5M$144.3M$144.0M$156.9M
Reservas-$660.7M-$721.3M-$778.9M-$850.1M-$910.0M-$964.3M-$1.01B-$1.04B-$1.07B-$1.08B
Patrimonio Neto$57.8M$38.9M$84.5M$57.1M$103.8M$84.6M$67.6M$52.6M$56.1M$64.2M
Deuda Total$19.4M$29.8M$29.9M$64.5M$66.9M$87.6M$87.2M$96.0M$98.1M$96.9M
Deuda Neta-$52.3M-$30.9M-$87.7M-$21.3M-$66.7M-$41.8M-$14.9M$30.1M$17.6M$14.1M
Capital Circulante$67.2M$66.8M$94.2M$77.8M$123.5M$108.5M$53.1M$76.9M$88.4M$73.6M

Balance (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Caja y Equivalentes$15.7M$20.0M$27.9M$18.0M
Activos Totales$215.2M$221.9M$222.9M$205.2M
Pasivos Totales$153.0M$156.9M$154.6M$134.5M
Patrimonio Neto$61.5M$64.2M$67.6M$70.0M
Deuda Total$98.2M$96.9M$97.4M$76.8M

Flujo de Caja (10 años)

Año2016201720182019202020212022202320242025
Beneficio Neto-$62.9M-$60.6M-$57.6M-$71.2M-$59.9M-$54.4M-$42.8M-$37.5M-$21.0M-$15.6M
Amortizaciones$1.8M$1.8M$1.4M$2.4M$3.1M$3.1M$3.0M$2.6M$1.9M$1.9M
Compensación en Acciones$8.1M$9.4M$10.4M$13.3M$18.0M$23.6M$24.5M$20.3M$22.9M$22.9M
Cambio en Capital Circulante-$950000-$3.6M$13.2M-$12.3M-$4.2M-$9.4M-$16.1M-$32.0M$5.2M-$6.8M
Flujo de Caja Operativo-$53.5M-$52.2M-$31.2M-$65.5M-$41.8M-$33.9M-$25.6M-$43.2M$11.4M$11.4M
Inversiones (CapEx)-$563000-$353000-$1.1M-$8.9M-$1.6M-$910000-$2.0M-$4.6M-$2.8M-$2.8M
Adquisiciones0-$3.5M000$910000-$10.5M000
Recompra de Acciones000000-$104000-$17500000
Dividendos Pagados0000000000
Flujo de Caja Libre-$54.1M-$52.6M-$32.4M-$74.4M-$43.4M-$34.8M-$27.6M-$47.8M$8.5M$8.5M

Flujo de Caja (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Flujo de Caja Operativo$1.9M$6.2M-$3.0M-$2.7M
Inversiones (CapEx)-$1.8M-$1.3M-$233000-$873000
Flujo de Caja Libre$94000$4.9M-$3.3M-$3.5M
Dividendos Pagados0000
Compensación en Acciones0$10.6M$4.9M$5.5M

Crecimiento y Márgenes (10 años)

Año2016201720182019202020212022202320242025
Crecimiento Ingresos (anual)+17.2%+39.8%+22.6%+23.1%+42.4%+23.8%-3.5%+15.3%+14.3%
Crecimiento Beneficio Neto (anual)+3.7%+5.0%-23.8%+16.0%+9.2%+21.3%+12.4%+44.2%+25.3%
Crecimiento BPA (anual)+9.7%+21.4%-15.9%+27.5%+13.5%+25.0%+12.5%+47.6%+25.5%
Cambio en Acciones (anual)+6.3%+21.7%+6.2%+17.2%+4.5%+3.1%+2.1%+2.4%+3.3%
Crecimiento FCF (anual)+2.8%+38.4%-129.8%+41.7%+19.8%+20.7%-73.0%+117.8%+0.0%
Margen Bruto45.4%48.3%48.1%55.2%55.2%51.5%53.7%55.3%55.2%54.5%
Margen Operativo-165.3%-132.0%-90.3%-88.7%-63.5%-37.4%-21.0%-19.2%-7.9%-4.2%
Margen EBITDA-157.2%-119.0%-85.2%-86.6%-55.9%-35.1%-20.7%-16.8%-5.6%-2.7%
Margen Neto-169.2%-139.1%-94.5%-95.4%-65.1%-41.6%-26.4%-24.0%-11.6%-7.6%
Margen FCF-145.5%-120.7%-53.2%-99.7%-47.2%-26.6%-17.0%-30.5%4.7%4.1%
Tasa Impositiva Efectiva-0.3%-6.9%-0.4%-0.4%-0.5%-0.6%-1.2%-0.9%-1.0%-2.3%

Datos por Acción (10 años)

Año2016201720182019202020212022202320242025
FCF por Acción$-0.53$-0.49$-0.25$-0.53$-0.26$-0.20$-0.16$-0.26$0.05$0.04
Dividendo por Acción$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Acciones en Circulación (Básicas)$101.5M$108.2M$130.8M$139.8M$163.9M$171.3M$176.5M$180.3M$184.6M$190.6M

Qué mirar en Salud / Farma

El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.

Rentabilidad

Rentabilidad sobre capital-10.31%
Rentabilidad sobre capital invertido-1.06%
Rentabilidad sobre activos-3.31%
Margen bruto52.05%
Margen operativo-0.73%
Margen neto-3.06%

Salud financiera

Deuda / Patrimonio1.10
Ratio corriente1.83

Ratios Clave (10 años)

Año2016201720182019202020212022202320242025
P/E-7.02-6.04-11.52-8.27-18.70-21.28-15.21-10.29-14.00-25.12
P/VC7.649.397.8510.3410.9313.789.537.405.066.11
P/V11.878.3910.897.9012.348.913.982.491.581.90
Margen Bruto45.4%48.3%48.1%55.2%55.2%51.5%53.7%55.3%55.2%54.5%
Margen Operativo-165.3%-132.0%-90.3%-88.7%-63.5%-37.4%-21.0%-19.2%-7.9%-4.2%
Margen Neto-169.2%-139.1%-94.5%-95.4%-65.1%-41.6%-26.4%-24.0%-11.6%-7.6%

Empresas relacionadas: CVRX · MASS · NPCE · QTRX · RXST · SENS · SGHT

Explorar sector: Healthcare · Medical - Devices

Más secciones de CERS: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos

Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones